In multivariate analysis adjusting for IDH1 mutation, age, gender and tumour grade, the combined TP53 mutation showed a trend for improved survival compared to WT, leading us to believe there are specific TP53 mutations accounting for the improved survival in the univariate analysis. This evidence concerns the gene TP53 and neoplasm.